← back to search

Paul Catalano

Harvard University · US

Area of research

Oncology · Pathology and Forensic Medicine

Research interest

Research interests include Cancer Immunotherapy and Biomarkers, Alcohol Consumption and Health Effects, Substance Abuse Treatment and Outcomes, and Head and Neck Cancer Studies.

h-index

15

citations

2,481

works

45

NIH funding

—

primary concept

Medicine

email

✉ Find email ↗

Recent publications

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

Nature Medicine 2020cited by 1,003position: middledoi

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma

JAMA Oncology 2020cited by 340position: middledoi

Radiation and PD-1 inhibition: Favorable outcomes after brain-directed radiation

Radiotherapy and Oncology 2017cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

— · 1 papers (2017–2017)— · 1 papers (2017–2017)Allison Taylor · Georgetown University1 papers (2017–2017)Leena Gandhi · Celldex Therapeutics (United States)1 papers (2017–2017)Tracy A. Balboni · Harvard University1 papers (2017–2017)Jonathan D. Schoenfeld · Harvard University1 papers (2017–2017)Patrick A. Ott · Harvard University1 papers (2017–2017)Daniel Cagney · Royal College of Surgeons in Ireland1 papers (2017–2017)Brian M. Alexander · Fox Chase Cancer Center1 papers (2017–2017)Luke Pike · University of Leicester1 papers (2017–2017)Ayal A. Aizer · Harvard University1 papers (2017–2017)Alexander Spektor · Harvard University1 papers (2017–2017)Elizabeth I. Buchbinder · The University of Texas Health Science Center at San Antonio1 papers (2017–2017)Bhupendra Rawal · Florida State University1 papers (2017–2017)F. Stephen Hodi · Harvard University1 papers (2017–2017)Mark M. Awad · PCAS (France)1 papers (2017–2017)